Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Fennec Pharmaceuticals Inc. (FENC) was the subject of an amended beneficial-ownership report by Sonic Fund II, L.P., Sonic GP LLC and Lawrence Kam. As of September 30, 2026, Kam may be deemed to beneficially own 1,592,559 shares, or 4.5%. The Fund directly holds 1,457,357 shares, and Sonic GP LLC may be deemed to own those shares through its role as the Fund’s general partner; Kam may be deemed to own them through his role as the GP’s managing member. Kam directly holds 135,202 shares with sole voting and dispositive power. Fennec had 35,305,117 shares outstanding as of November 10, 2026, the basis cited for the ownership percentages.
Key Figures
Beneficial ownership attributed to Lawrence Kam:1,592,559 sharesOwnership percentage attributed to Lawrence Kam:4.5%Shares held directly by Lawrence Kam:135,202 shares+3 more
6 metrics
Beneficial ownership attributed to Lawrence Kam1,592,559 sharesAs of September 30, 2026; 4.5% of the class
Ownership percentage attributed to Lawrence Kam4.5%Based on 1,592,559 shares as of September 30, 2026
Shares held directly by Lawrence Kam135,202 sharesWith sole voting and dispositive power
Shares attributed to Sonic Fund II, L.P.1,457,357 sharesAs of September 30, 2026; 4.1% of the class
Ownership percentage attributed to Sonic Fund II, L.P.4.1%Based on 1,457,357 shares
Fennec shares outstanding35,305,117 sharesAs of November 10, 2026; basis cited for the ownership percentages
Key Terms
beneficially owned, shared voting power, shared dispositive power, sole voting power, +1 more
5 terms
beneficially ownedtechnical
"may be deemed to have beneficially owned 1,592,559 Shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting powertechnical
"Shared Voting Power 1,457,357.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powertechnical
"Shared Dispositive Power 1,457,357.00"
sole voting powertechnical
"Sole Voting Power 135,202.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive powertechnical
"Sole Dispositive Power 135,202.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many FENC shares did the reporting persons beneficially own?
As of September 30, 2026, Lawrence Kam may be deemed to beneficially own 1,592,559 shares, or 4.5%. Sonic Fund II, L.P. and Sonic GP LLC each reported 1,457,357 shares, or 4.1%; those figures reflect attribution of the Fund’s shares through the GP relationship and are not separate holdings to add together.
How many FENC shares did Lawrence Kam hold directly?
Lawrence Kam directly held 135,202 shares with sole voting and dispositive power as of September 30, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 4)
Fennec Pharmaceuticals Inc. ("Issuer")
(Name of Issuer)
Common stock, no par value (the "Shares")
(Title of Class of Securities)
31447P100
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
31447P100
1
Names of Reporting Persons
Sonic Fund II, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,457,357.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,457,357.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,457,357.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.1 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
31447P100
1
Names of Reporting Persons
Sonic GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,457,357.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,457,357.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,457,357.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.1 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
31447P100
1
Names of Reporting Persons
Lawrence Kam
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
135,202.00
6
Shared Voting Power
1,457,357.00
7
Sole Dispositive Power
135,202.00
8
Shared Dispositive Power
1,457,357.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,592,559.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.5 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Fennec Pharmaceuticals Inc. ("Issuer")
(b)
Address of issuer's principal executive offices:
PO Box 13628, 68 TW Alexander Drive, Research Triangle Park, NC 27709
Item 2.
(a)
Name of person filing:
The names of the persons filing this statement on Schedule 13G (collectively, the "Reporting Persons") are:
* The Sonic Fund II, L.P. (the "Fund").
* Sonic GP LLC (the "General Partner").
* Lawrence Kam.
(b)
Address or principal business office or, if none, residence:
The address of the principal offices of each of the Reporting Persons is 400 Hobron Lane, Suite 3709, Honolulu, HI 96815.
(c)
Citizenship:
The Fund and the General Partner are organized under the laws of the State of Delaware. Mr. Kam is a citizen of the United States of America.
(d)
Title of class of securities:
Common stock, no par value (the "Shares")
(e)
CUSIP No.:
31447P100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of September 30, 2026, the Reporting Persons may be deemed to have beneficially owned 1,592,559 Shares.
The Fund holds the Shares directly. The General Partner is the General Partner of the Fund, and by virtue of that relationship, the General Partner may be deemed to beneficially own the Shares owned directly by the Fund. Mr. Kam is the managing member of the General Partner, and by virtue of this relationship, Mr. Kam may be deemed to beneficially own the Shares beneficially owned by the General Partner. Mr. Kam directly holds the shares over which he has sole voting and dispositive power.
(b)
Percent of class:
4.5% (based upon 35,305,117 Shares outstanding, which is the total number of Shares outstanding as of November 10, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 12, 2026).
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Cover Pages Items 5-9.
(ii) Shared power to vote or to direct the vote:
See Cover Pages Items 5-9.
(iii) Sole power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
(iv) Shared power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit A to the Schedule 13G/A filed by the Reporting Persons with the Securities and Exchange Commission on February 17, 2026.
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Sonic Fund II, L.P.
Signature:
/s/ Lawrence Kam
Name/Title:
Lawrence Kam, Managing Member of Sonic GP LLC, its General Partner